We are live on ! Find out more
OXFD

Oxford Immunotec Global PLC Ordinary Shares
OXFD

Delisted

OXFD was delisted on the 5th of March, 2021.

Back to rankings

47 hedge funds and large institutions have $205M invested in Oxford Immunotec Global PLC Ordinary Shares in 2014 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

80% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 10

13% more capital invested

Capital invested by funds: $181M → $205M (+$23.9M)

12% more funds holding

Funds holding: 42 → 47 (+5)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
47
Holders Change
+5
Holders Change %
+11.9%
% of All Funds
1.36%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
11
Increased
18
Reduced
10
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
+$18M
2
NCGI
Next Century Growth Investors
Minnesota
+$6.51M
3
O
OppenheimerFunds
New York
+$5.72M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.98M
5
CAM
Cortina Asset Management
Wisconsin
+$4.7M

Top Sellers

Rank Fund Capital Flow
1
DCC
Dow Chemical Company
Michigan
-$7.17M
2
RG
Redmile Group
California
-$6.96M
3
PC
Polar Capital
United Kingdom
-$5.83M
4
FCM
Farallon Capital Management
California
-$4.59M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$2.83M
Name Holding Trade Value Shares
Change 		Change in
Stake
BIM
26
BlackRock Investment Management
Delaware
$1.26M +$10.2K +470 +0.8%
BIT
27
BlackRock Institutional Trust
California
$1.23M +$59.8K +2,764 +5%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$709K +$329K +15,188 +75%
Ameriprise
29
Ameriprise
Minnesota
$568K +$612K +28,300 New
California Public Employees Retirement System
30
California Public Employees Retirement System
California
$530K +$481K +22,213 +394%
WCM
31
Waterstone Capital Management
Minnesota
$502K +$541K +25,000 New
FA
32
Friess Associates
Delaware
$450K +$485K +22,400 New
TCIM
33
TIAA CREF Investment Management
New York
$321K – – –
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$225K – – –
Vanguard Group
35
Vanguard Group
Pennsylvania
$203K +$219K +10,114 New
TA
36
Teachers Advisors
New York
$122K – – –
NFA
37
Nationwide Fund Advisors
Ohio
$96K – – –
AIG
38
American International Group
New York
$84.1K +$2.19K +101 +2%
SO
39
STRS Ohio
Ohio
$50K – – –
Barclays
40
Barclays
United Kingdom
$41K +$42.4K +1,962 +1,982%
PAM
41
Panagora Asset Management
Massachusetts
$21K +$23K +1,065 New
Citigroup
42
Citigroup
New York
$19K -$44.7K -2,068 -68%
MAA
43
Managed Account Advisors
New Jersey
$17K -$22.8K -1,054 -55%
U
44
UBS
Switzerland
$2K +$346 +16 +19%
Morgan Stanley
45
Morgan Stanley
New York
$1K +$584 +27 +300%
Manulife (Manufacturers Life Insurance)
46
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$61 +$66.2K +3,060 New
DCC
47
Dow Chemical Company
Michigan
– -$7.17M -370,148 Closed
PC
48
Polar Capital
United Kingdom
– -$5.83M -301,078 Closed
FCM
49
Farallon Capital Management
California
– -$4.59M -237,000 Closed
GP
50
Grow Partners
California
– -$969K -50,000 Closed
1
2
3

OXFD Hedge Fund Activity: Q1 2014 in Review

47 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q1 2014, worth a combined $205M — up 13% from $181M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new OXFD positions and 6 closed out — a net gain of 5 holders — while 18 added to existing stakes and 10 trimmed.

The largest buyer was Invesco, adding an estimated $18M. The largest seller was Dow Chemical Company, exiting entirely with an estimated $7.17M sold.

  • 47 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q1 2014, up from 42 in Q4 2013.
  • Funds reported $205M of Oxford Immunotec Global PLC Ordinary Shares stock for Q1 2014, up 13% quarter-over-quarter.
  • 11 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q1 2014 and 6 closed out, a net change of +5 holders.
  • The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q1 2014 was Invesco, an estimated $18M added.
  • The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q1 2014 was Dow Chemical Company, an estimated $7.17M sold.

Based on aggregated 13F filings for Q1 2014.